Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Pyr-His-Trp-Ser-Tyr-D-Lys(doxorubicinylglutarate)-Leu-Arg-Pro-Gly-NH2, acetate salt

EU orphan designation number: EU/3/10/766   
Active ingredient: Pyr-His-Trp-Ser-Tyr-D-Lys(doxorubicinylglutarate)-Leu-Arg-Pro-Gly-NH2, acetate salt
Indication: Treatment of ovarian cancer
Sponsor: Æterna Zentaris GmbH
Weismüllerstr. 50, D-60314 Frankfurt am Main, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2010 Orphan Designation EMA/OD/014/10 (2010)5533 of 04/08/2010